Y-Biologics, Inc. (KOSDAQ: A338840)
Health Care · Biotechnology · KR
₩8,520.00
+2.16% today · -46.1% 1Y
Y-Biologics, Inc. (KOSDAQ: A338840) operates in the Biotechnology industry within the Health Care sector. The company is valued at $97.21M.
Over the last twelve months the share price has lost 46.1%, trading between 7.23K and 38.00K.
Tweenvest scores Y-Biologics, Inc. across four factors: quality 38/100, value 34/100, growth 0/100. Its strongest factor is quality.
A338840 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $97.21M
- Revenue (TTM)
- $2.05M
- P/E
- —
- EPS
- -3,303.05
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- ₩38,000.00
- 52-week low
- ₩7,230.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.37M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Faron Pharmaceuticals OyAIM: FARN | $99.74M | £0.37 | +5.19% |
| Pet Pharm Biotech Co., Ltd.TPEX: 7762 | $99.39M | NT$54.50 | +2.44% |
| SynAct Pharma ABOM: SYNACT | $99.32M | Skr16.90 | -5.06% |
| Novogenia AGMUN: 7V0 | $98.11M | €7.20 | — |
| Senhwa Biosciences, Inc.TPEX: 6492 | $96.53M | NT$34.40 | +0.58% |
| Medivir AB (publ)OM: MVIR | $96.31M | Skr1.55 | -2.15% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $95.68M | $1.37 | +3.79% |
| Atara Biotherapeutics, Inc.NasdaqGS: ATRA | $94.05M | $9.23 | -1.49% |
Figures last refreshed Oct 4, 2026.